SWP
GSK icon

Sagespring Wealth Partners’s GSK GSK Stock Holding History

Sagespring Wealth Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$496K Sell
9,464
-564
-6% -$29.8K 0.01% 532
2026
Q1 		$553K Sell
10,028
-1,002
-9% -$54.3K 0.01% 472
2025
Q4 		$541K Buy
11,030
+716
+7% +$33.4K 0.01% 455
2025
Q3 		$445K Buy
10,314
+73
+0.7% +$2.85K 0.01% 490
2025
Q2 		$393K Buy
10,241
+4,823
+89% +$184K 0.01% 500
2025
Q1 		$210K Buy
+5,418
New +$198K 0.01% 629

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Sagespring Wealth Partners's GSK Position: Q2 2026 in Review

Sagespring Wealth Partners reduced its GSK (GSK) stake by 5.6% in Q2 2026, selling an estimated $29.8K and leaving 9,464 shares worth $496K. The position accounts for 0.01% of the portfolio, ranked #532.

Sagespring Wealth Partners first reported a position in GSK in Q1 2025 and has held it in 6 quarters since. The position peaked at $553K in Q1 2026. 1,042 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Sagespring Wealth Partners held 9,464 shares of GSK worth $496K as of Q2 2026.
  • Sagespring Wealth Partners sold 564 GSK shares in Q2 2026, an estimated $29.8K.
  • GSK made up 0.01% of Sagespring Wealth Partners's portfolio in Q2 2026, its #532 holding.
  • Sagespring Wealth Partners first reported a position in GSK in Q1 2025 and has held it in 6 quarters since.
  • Sagespring Wealth Partners's GSK position peaked at $553K in Q1 2026.
  • 1,042 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Sagespring Wealth Partners's 13F filing for Q2 2026, filed 3 Aug 2026.